Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov 9:14:1286344.
doi: 10.3389/fimmu.2023.1286344. eCollection 2023.

Crosstalk: keratinocytes and immune cells in psoriasis

Affiliations
Review

Crosstalk: keratinocytes and immune cells in psoriasis

Masahiro Kamata et al. Front Immunol. .

Abstract

In the past, psoriasis was considered a skin disease caused only by keratinocyte disorders. However, the efficacy of immunosuppressive drugs and biologics used to treat psoriasis proves that psoriasis is an immune-mediated disease. Indeed, a variety of immune cells are involved in the pathogenesis of psoriasis, including dendritic cells, Th17 cells, and resident memory T cells. Furthermore, keratinocytes play a role in the development of psoriasis as immune cells by secreting antibacterial peptides, chemokines, tumor necrosis factor-α, interleukin (IL)-36, and IL-23. These immune cells and skin cells interact and drive the aberrant differentiation and proliferation of keratinocytes. This crosstalk between keratinocytes and immune cells critical in the pathogenesis of psoriasis forms an inflammatory loop, resulting in the persistence or exacerbation of psoriasis plaques.

Keywords: crosstalk; immune cell; keratinocyte; psoriasis; skin cell.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Crosstalk from immune cells to keratinocytes in psoriasis. A variety of immune cells affect keratinocytes in psoriasis. IL, interleukin; TNF, tumor necrosis factor; NKT, natural killer T; MAIT, mucosal-associated invariant T.
Figure 2
Figure 2
Crosstalk from keratinocytes to immune cells in psoriasis. Activated keratinocytes produce antibacterial peptides, chemokines, and inflammatory cytokines, and affect immune cells in psoriasis. pDC, plasmacytoid dendritic cell; mDC, myeloid DC; CXCL, C-X-C motif chemokine ligand; CCL, C-C motif chemokine ligand; IL, interleukin; TNF, tumor necrosis factor.

References

    1. Kamata M, Tada Y. Efficacy and safety of biologics for psoriasis and psoriatic arthritis and their impact on comorbidities: A literature review. Int J Mol Sci (2020) 21(5):1690. doi: 10.3390/ijms21051690 - DOI - PMC - PubMed
    1. Kamata M, Tada Y. Safety of biologics in psoriasis. J Dermatol (2018) 45:279–86. doi: 10.1111/1346-8138.14096 - DOI - PubMed
    1. Yamanaka K, Yamamoto O, Honda T. Pathophysiology of psoriasis: A review. J Dermatol (2021) 48:722–31. doi: 10.1111/1346-8138.15913 - DOI - PubMed
    1. Chiricozzi A, Guttman-Yassky E, Suárez-Fariñas M, Nograles KE, Tian S, Cardinale I, et al. . Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol (2011) 131:677–87. doi: 10.1038/jid.2010.340 - DOI - PubMed
    1. Teunissen MB, Koomen CW, de Waal Malefyt R, Wierenga EA, Bos JD. Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol (1998) 111:645–9. doi: 10.1046/j.1523-1747.1998.00347.x - DOI - PubMed